News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan Pharmaceuticals, Inc. (MYL)'s Generic Version of Blood-Thinner Plavix Gets FDA Approval



5/18/2012 6:29:00 AM

Clopidogrel - known in branded form as Plavix - is the blood-thinning drug taken by millions to avoid heart attacks and strokes and it will soon be on pharmacy shelves as a generic drug. Plavix was made through a partnership of Sanofi-Aventis and Bristol-Myers Squibb and had U.S. sales of approximately $6.7 billion for the 12 months ending March 31, 2012, according to IMS Health. The U.S. Food and Drug Administration gave approval Thursday to the generic version produced by Pittsburgh-based Mylan Pharmaceuticals. Mylan said it will begin shipping tablets immediately.

Read at Philadelphia Inquirer
Read at BusinessWeek
Read at Reuters
Read at Nasdaq
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES